Analysis of Ras Transformation of Human Thyroid Epithelial Cells

Methods in Enzymology

Volumn 407, Issue , 2006, Pages 648-660

  Poghosyan, Zaruhi ^a   Wynford Thomas, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; RAF PROTEIN;

CARCINOGENESIS; CELL LINE; CELL MANIPULATION; CELL PROLIFERATION; CLINICAL PROTOCOL; EPITHELIUM CELL; FIBROBLAST; HUMAN; IN VIVO STUDY; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROVIRUS; REVIEW; THYROID FOLLICLE CELL; THYROID TUMOR;

RODENTIA;

EID: 33744525094     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)07051-5     Document Type: Review

References (26)

1. Bond J.A., Wyllie F.S., Rowson J., Radulescu A., and Wynford-Thomas D. In vitro reconstruction of tumour initiation in a human epithelium. Oncogene 9 (1994) 281-290
2. Bos J.L. Ras oncogenes in human cancer: A review. Cancer Res. 49 (1989) 4682-4689
3. Bounacer A., McGregor A., Skinner J., Bond J., Poghosyan Z., and Wynford-Thomas D. Mutant ras-induced proliferation of human thyroid epithelial cells requires three effector pathways. Oncogene 23 (2004) 7839-7845
4. Bredel M., and Pollack I.F. The p21-Ras signal transduction pathway and growth regulation in human high-grade gliomas. Brain Res. Brain Res. Rev. 29 (1999) 232-249
5. Cowley S., Paterson H., Kemp P., and Marshall C.J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77 (1994) 841-852
6. Elenbaas B., Spirio L., Koerner F., Fleming M.D., Zimonjic D.B., Donaher J.L., Popescu N.C., Hahn W.C., and Weinberg R.A. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15 (2001) 50-65
7. Francis-Lang H., Zannini M., De Felice M., Berlingieri M.T., Fusco A., and Di Lauro R. Multiple mechanisms of interference between transformation and differentiation in thyroid cells. Mol. Cell. Biol. 12 (1992) 5793-5800
8. Gire V., Marshall C., and Wynford-Thomas D. PI-3-kinase is an essential antiapoptotic effector in the proliferative response of primary human epithelial cells to mutant RAS. Oncogene 19 (2000) 2269-2276
9. Gire V., Marshall C.J., and Wynford-Thomas D. Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant Ras. Oncogene 18 (1999) 4819-4832
10. Gire V., and Wynford-Thomas D. RAS oncogene activation induces proliferation in normal human thyroid epithelial cells without loss of differentiation. Oncogene 19 (2000) 737-744
11. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., and Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature 400 (1999) 464-468
12. Leevers S.J., and Marshall C.J. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 11 (1992) 569-574
13. Lemoine N.R., Mayall E.S., Wyllie F.S., Farr C.J., Hughes D., Padua R.A., Thurston V., Williams E.D., and Wynford-Thomas D. Activated ras oncogenes in human thyroid cancers. Cancer Res. 48 (1988) 4459-4463
14. Lemoine N.R., Mayall E.S., Wyllie F.S., Williams E.D., Goyns M., Stringer B., and Wynford-Thomas D. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4 (1989) 159-164
15. Marshall C.J. Ras effectors. Curr. Opin. Cell. Biol. 8 (1996) 197-204
16. Miller M.J., Prigent S., Kupperman E., Rioux L., Park S.H., Feramisco J.R., White M.A., Rutkowski J.L., and Meinkoth J.L. RalGDS functions in Ras-and cAMP-mediated growth stimulation. J. Biol. Chem. 272 (1997) 5600-5605
17. Miller M.J., Rioux L., Prendergast G.V., Cannon S., White M.A., and Meinkoth J.L. Differential effects of protein kinase A on Ras effector pathways. Mol. Cell. Biol. 18 (1998) 3718-3726
18. Rich J.N., Guo C., McLendon R.E., Bigner D.D., Wang X.F., and Counter C.M. A genetically tractable model of human glioma formation. Cancer Res. 61 (2001) 3556-3560
19. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 (1997) 593-602
20. Skinner J., Bounacer A., Bond J.A., Haughton M.F., deMicco C., and Wynford-Thomas D. Opposing effects of mutant ras oncoprotein on human fibroblast and epithelial cell proliferation: Implications for models of human tumorigenesis. Oncogene 23 (2004) 5994-5999
21. Suarez H.G., du Villard J.A., Severino M., Caillou B., Schlumberger M., Tubiana M., Parmentier C., and Monier R. Presence of mutations in all three ras genes in human thyroid tumors. Oncogene 5 (1990) 565-570
22. Trahey M., Milley R.J., Cole G.E., Innis M., Paterson H., Marshall C.J., Hall A., and McCormick F. Biochemical and biological properties of the human N-ras p21 protein. Mol. Cell. Biol. 7 (1987) 541-544
23. Wei W., Hemmer R.M., and Sedivy J.M. Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol. Cell. Biol. 21 (2001) 6748-6757
24. Wolthuis R.M., and Bos J.L. Ras caught in another affair: The exchange factors for Ral. Curr. Opin. Genet. Dev. 9 (1999) 112-117
25. Wynford-Thomas D. Molecular basis of epithelial tumorigenesis: The thyroid model. Crit. Rev. Oncog. 4 (1993) 1-23
26. Wynford-Thomas D. Origin and progression of thyroid epithelial tumours: Cellular and molecular mechanisms. Horm. Res. 47 (1997) 145-157